LifeMD, Inc. (LFMD)
Market Cap | 436.76M |
Revenue (ttm) | 152.55M |
Net Income (ttm) | -23.70M |
Shares Out | 40.37M |
EPS (ttm) | -0.70 |
PE Ratio | n/a |
Forward PE | 32.15 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 394,618 |
Open | 10.95 |
Previous Close | 11.16 |
Day's Range | 10.51 - 11.05 |
52-Week Range | 1.40 - 12.01 |
Beta | 1.43 |
Analysts | Strong Buy |
Price Target | 12.80 (+18.3%) |
Earnings Date | May 10, 2024 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair lo... [Read more]
Financial Performance
In 2023, LifeMD's revenue was $152.55 million, an increase of 28.15% compared to the previous year's $119.03 million. Losses were -$23.70 million, -51.27% less than in 2022.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for LFMD stock is "Strong Buy." The 12-month stock price forecast is $12.8, which is an increase of 18.30% from the latest price.
News
LifeMD to Report First Quarter 2024 Financial Results on May 8
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen...
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needha...
LifeMD Reports Fourth Quarter 2023 Results
Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year...
LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11th Annual BTIG MedTech, Digital Health, ...
LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Con...
LifeMD Stock Pops on Medifast Agreement. It's All About Weight-Loss Drugs.
The companies are teaming up to offer a ‘transformative weight management solution.'
LifeMD's stock soars 9.5% on news company is teaming up with Medifast to create weight-management program that includes GLP-1 drugs
LifeMD Inc.'s stock LFMD, +1.76% soared 9% early Wednesday, after the virtual primary care provider said it's teaming up with Medifast Inc. MED, +1.03%, a wellness company known for its habit-based an...
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business...
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
Collaboration will integrate LifeMD's telehealth platform and GLP-1 offering for medically qualified patients with OPTA VIA Coach-guided, healthy lifestyle solution
LifeMD Executives to Participate in RWJBarnabas Health's Telehealth Symposium
NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium ...
LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA
Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues. Adjusted EPS of $0.08 per share compared with a loss of $0.03 in the year-ago perio...
Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy
Joint Research Study Proved Particle's Platform Can Help Providers Contextualize and Comprehend Patient Data to Improve Care and Identify Those Eligible for GLP-1 Treatment Joint Research Study Proved...
LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today launched a partnership with ASCEND Therapeutics US, LLC, a subsidia...
LifeMD to Participate in Two Investor Conferences in September
NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced that management will be participating in two upcoming investor conferences in September.
LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance
Revenue grew 18% year-over-year to a record $35.9 million; telehealth net revenues increased 11% versus the first quarter of 2023. Achieved positive free cash flow, ahead of guidance.
LifeMD to Report Second Quarter 2023 Financial Results on August 9
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended...
LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements
Proprietary platform enhancements elevate LifeMD's GLP-1 weight management program with best-in-class clinician-directed care and personalized guidance Proprietary platform enhancements elevate LifeMD...
LifeMD Appoints William J. Febbo to its Board of Directors
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executiv...
LifeMD, Inc. to Present at the June 1st Virtual Investor Summit
New York, New York--(Newsfile Corp. - May 23, 2023) - LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the virtua...
LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended March 31, 2023. All figure compar...
LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement
NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced that it has entered into an agreement to be the exclusive t...
LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023
NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first ...
LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the launch of new membership plans that enable immediate ...
LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA Profitability
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and full year ended December 31, 2022....